The reduced relapse rate among postmenopausal women could be due to diminished immune system activity, according to the authors.
Multiple sclerosis (MS) is about three times more prevalent in women than men, and hormonal differences are believed to be the culprit. Research suggests that MS symptoms may improve during pregnancy, potentially due to changes in hormone levels that mediate T-cell activity. However, relapse rates are typically higher than before pregnancy immediately postpartum.
After menopause, a shift in hormone balance leads to a decrease in blood estrogen levels, which may affect MS disease progression. Zahra Shahraki, associate professor at the Zabol University of Medical Sciences in Iran, and her colleagues conducted a systematic review and meta-analysis to gauge the effect of menopause on relapse rate and disability status in patients with MS. Their results were published earlier this month in the journal BMC Neurology.
After searching several databases, the researchers included four studies published between 2017 and 2020. Each study enrolled between 37 and 148 patients with a mean age range between 47 and 50 years. Two studies took place in Italy, one in Portugal, and one in Spain.
Results showed that the mean annual relapse rate significantly decreased after menopause compared to premenopausal time. However, mean disability scores measured with the Expanded Disability Status Scale (EDSS) significantly increased post menopause versus pre-menopause. Premenopausal EDSS scores ranged from 1.5 to 2, indicating patients had no disability with minimal symptoms or minimal disability. After menopause, mean EDSS scores ranged from 2 to 3.1, signifying moderate disability.
The authors note that postmenopausal reduced relapse rates could be due to decreased immune system activity, and reduced neuroprotection due to decreased estrogen levels may contribute to the increased disability levels.
They wrote, “It is evident that the anti-inflammatory role of [estrogens] after menopause decreases, which leads to aggressive, inflammatory damage of axons plus myelin sheets, as well as disability progression.”
Study Reveals Patients Benefit More with Female Doctors — More Particularly Female Patients
April 30th 2024Understanding how physician sex contributes to these disparities is crucial as evidence on the impact of physician sex on clinical outcomes remains limited, especially around patient sex.
Read More
The proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System introduces strategies to improve the well-being of Medicare beneficiaries, including efforts to tackle social determinants of health, create more robust emergency readiness and enhance maternal healthcare.
Read More
The IRA’s Impact on Women in Medicare
April 2nd 2024In 2025, the out-of-pocket cap and other Part D related provisions in the Inflation Reduction Act are projected to save women in Medicare an average of 28% in out-of-pocket costs, according to a new analysis from the Office of the Assistant Secretary for Planning and Evaluation.
Read More
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More